Literature DB >> 12769734

Biodefense properties of milk: the role of antimicrobial proteins and peptides.

D A Clare1, G L Catignani, H E Swaisgood.   

Abstract

Mammary fluids, colostrum and milk, deliver nature's first host defense systems upon birth, and these essential liquids are critical for survival of the neonate. The identification and characterization of anti-infectious proteins were among the early scientific discoveries and this group of proteins has long been recognized for promoting health benefits in both newborns and adults. Among the more widely studied are the immunoglobulins, lactoperoxidase, lysozyme, and lactoferrin. Recently, it was shown that alpha--lactalbumin may also function in a protective capacity dependent upon its folding state. Some of these, especially lactoferrin, also display an immunomodulatory role in which case a totally separate cascade of host defense responses is initiated. It was noted that the mechanism of action for this cluster of sentry proteins does vary; thus, this protective strategy provides for a broad range of responsive reactions to infection. Presently, there is a major focus on the discovery of novel peptides that can be generated from existing milk proteins via proteolytic reactions. To date, this substrate list includes alpha--lactalbumin, beta-lactoglobulin, all casein fractions, and lactoferrin. Again, the immunoregulatory effects prompted as a result of the appearance of these peptides are currently being defined. Herein, we review the principal biological properties associated with each of these contributing milk components with a special emphasis on the role of biodefensive milk peptides. We envision future contributions emerging from this research field as an opportunity to develop effective new therapies to be used in treating infectious diseases and promoting health benefits in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12769734     DOI: 10.2174/1381612033454874

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  24 in total

1.  Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.

Authors:  Senthil Kumar Velusamy; Daniel H Fine; Kabilan Velliyagounder
Journal:  Microbes Infect       Date:  2014-08-11       Impact factor: 2.700

Review 2.  α-Lactalbumin, Amazing Calcium-Binding Protein.

Authors:  Eugene A Permyakov
Journal:  Biomolecules       Date:  2020-08-20

Review 3.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

4.  Impact of pasteurization on the antibacterial properties of human milk.

Authors:  Marjan Van Gysel; Veerle Cossey; Steffen Fieuws; Annette Schuermans
Journal:  Eur J Pediatr       Date:  2012-05-12       Impact factor: 3.183

Review 5.  Antimicrobial peptides and colitis.

Authors:  Samantha Ho; Charalabos Pothoulakis; Hon Wai Koon
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways.

Authors:  Pilar Requena; Abdelali Daddaoua; Emilia Guadix; Antonio Zarzuelo; María Dolores Suárez; Fermín Sánchez de Medina; Olga Martínez-Augustin
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

7.  Examination of the activity of camel milk casein against hepatitis C virus (genotype-4a) and its apoptotic potential in hepatoma and hela cell lines.

Authors:  Osama Almahdy; Esmail M El-Fakharany; Ehab El-Dabaa; Tzi Bun Ng; Elrashdy M Redwan
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

8.  Anti-inflammatory potential of a malleable matrix composed of fermented whey proteins and lactic acid bacteria in an atopic dermatitis model.

Authors:  Josée Beaulieu; Claude Dupont; Pierre Lemieux
Journal:  J Inflamm (Lond)       Date:  2007-03-21       Impact factor: 4.981

9.  Development of a surface display ELISA to detect anti-IgG antibodies against bovine αS1-casein in human sera.

Authors:  Thorsten Saenger; Achim Braukmann; Stefan Vordenbäumen; Irina Altendorfer; Ellen Bleck; Heidrun Hochwallner; Rudolf Valenta; Matthias Schneider; Joachim Jose
Journal:  J Pharm Biomed Anal       Date:  2014-03-30       Impact factor: 3.935

10.  Lactobacillus helveticus: the proteolytic system.

Authors:  M W Griffiths; A M Tellez
Journal:  Front Microbiol       Date:  2013-03-05       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.